Efficacy and safety of local consolidative therapy combined with systemic therapy in driver-negative oligometastatic non-small cell lung cancer: a systematic review and meta-analysis
{{output}}
Oligometastatic non-small cell lung cancer (NSCLC) represents a potentially modifiable stage of metastatic disease, however, the survival benefit of local consolidative therapy (LCT) in patients without actionable driver mutations remains uncertain in the era ... ...
